Reinventing Drug Discovery, from Retrospective to Perspectives

10th NovAliX Conference - Anniversary Edition

 Brunnen, Switzerland    June 2-4, 2024

Vision for the Future of Drug Discovery

Vision, Agility, Mindset: Catalyzing the Transformation of Drug Discovery for Patients at Servier

Dr Claude BERTRAND
INSTITUT DE RECHERCHES SERVIER, GIF-SUR-YVETTE, France
Read more

Title of talk to be announced

Dr Karin BRINER
GENENTECH, South San Francisco, United States

25 Years of Thinking Small

Dr Harren JHOTI
ASTEX PHARMACEUTICALS, Cambridge, United Kingdom
Read more

Enabling New Paradigms in Drug Discovery Through Biophysical Characterization - virtual lecture

Dr Frank LAUKIEN
BRUKER, Billerica, United States
Read more
Dr Falko BUSSE
BRUKER SWITZERLAND, Fällanden, Switzerland
Read more

Adding Years of Life and Quality of Life: How the Healthcare Industry Can Bring Value to the World

Dr Paul STOFFELS
GALAPAGOS, Beerse, Belgium
Read more

Present and Future Tools for Drug Discovery

The SGC over 20 Years: Open Experimental Data, Knowledge and Reagents Enabling Drug Discovery

Prof. Cheryl ARROWSMITH
STRUCTURAL GENOMICS CONSORTIUM, Toronto, Canada
Read more

Title of talk to be announced

Dr Maria M. FLOCCO
ASTRAZENECA, Cambridge, United Kingdom
Read more

Where AI Meets the Real World

Dr Dave HALLETT
EXSCIENTIA LTD, Oxford, United Kingdom
Read more

Title of talk to be confirmed

Prof. Holger STARK
MAX PLANCK INSTITUTE FOR MULTIDISCIPLINARY SCIENCES, Göttingen, Germany

New Modalities as New Frontiers of Drug Discovery

Biophysics for Protein Degraders: It’s all in the Ternary Complex

Prof. Alessio CIULLI
UNIVERSITY OF DUNDEE, Dundee, United Kingdom
Read more

Chance Favors the Perplexed Mind: The Critical Role of Biochemistry and Biophysics in the Development of Small Molecule Inhibitors of Chromatin- and RNA-Modifying Enzymes as Precision Cancer Therapeutics

Dr Robert COPELAND
ACCENT THERAPEUTICS, INC., Lexington, United States
Read more

Induced Proximity: Exploring New Therapeutic Modalities

Prof. Craig CREWS
YALE UNIVERSITY, New Haven, CT, United States
Read more

Unmet Therapeutic Needs : Current Challenges

Gene Therapy of Rare Diseases. A Quantum Leap in Medicine.

Dr Serge BRAUN
AFM TÉLÉTHON, Evry, France

Building a Pipeline of High-Impact Products to Prevent, Diagnose and Treat Bacterial Infections

Dr Erin DUFFY
CARB-X, Boston, United States
Read more

Drug Discovery for Neglected Patients: Past Experience, Present Strategy and Future Directions

Dr Charlie MOWBRAY
DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI), Geneva, Switzerland

Challenges and Opportunities in Cancer Therapy: a Perspective Across Modalities

Dr Tobias SCHMELZLE
NOVARTIS, Basel, Switzerland
Read more

Financial Perspectives on the Future of the Industry

Title of talk to be announced

Dr Matthias BUCHER
CEPTON STRATEGIES, Paris, France

Title of talk to be announced

Dr Vanessa MALIER
IVIBIOPLUS, Paris, France

Financing Early Stage Life Sciences Innovation in Europe: a New Model of Venture Building

Dr Magali RICHARD
HOME BIOSCIENCES, Paris, France
Read more

Round table Contributors

Dr Chun-wa CHUNG
GLAXOSMITHKLINE, Stevenage, United Kingdom

Prof. Helena DANIELSON
UPPSALA UNIVERSITY, Uppsala, Sweden

Dr Matthias FRECH
MERCK, Darmstadt, Germany

Dr Stefan GESCHWINDNER
ASTRAZENECA, Mölndal, Sweden

Dr Sylwia HUBER
F. HOFFMANN-LA ROCHE, Basel, Switzerland

Dr Sandra JACOB
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland

Dr Herbert NAR
BOEHRINGER INGELHEIM, Biberach, Germany